VioQuest Pharmaceuticals, Inc.
VOQP · OTC
12/31/2007 | 12/31/2006 | 12/31/2005 | 12/31/2004 | |
|---|---|---|---|---|
| Market Cap | $4,672 | $20,689 | $16,526 | $13,680 |
| - Cash | $695 | $2,931 | $6,021 | $3,066 |
| + Debt | $2,930 | $265 | $265 | $0 |
| Enterprise Value | $6,908 | $18,022 | $10,769 | $10,615 |
| Revenue | $0 | $0 | $3,805 | $1,485 |
| % Growth | – | -100% | 156.2% | – |
| Gross Profit | $0 | $0 | $1,377 | $647 |
| % Margin | – | – | 36.2% | 43.6% |
| EBITDA | -$6,612 | -$5,153 | -$10,352 | -$3,586 |
| % Margin | – | – | -272.1% | -241.5% |
| Net Income | -$10,892 | -$8,271 | -$12,835 | -$4,024 |
| % Margin | – | – | -337.3% | -270.9% |
| EPS Diluted | -2.33 | -2.08 | -5.82 | -2.35 |
| % Growth | -12% | 64.3% | -147.7% | – |
| Operating Cash Flow | -$7,082 | -$6,458 | -$3,742 | -$3,786 |
| Capital Expenditures | -$5 | -$28 | -$615 | -$357 |
| Free Cash Flow | -$7,087 | -$6,486 | -$4,357 | -$4,143 |